Abhishek Jain - 01 Aug 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Aug 2025, 16:25:13 UTC
Prior SEC filing
29 May 2025
Next SEC filing
02 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact

Key filing fact

Abhishek Jain filed Form 4 for CareDx, Inc. (CDNA) on 05 Aug 2025.

Key facts

  • This page summarizes Abhishek Jain's Form 4 filing for CareDx, Inc. (CDNA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2025, 16:25.

Change

  • Previous filing in this sequence was filed on 29 May 2025.
  • Current net transaction value: -$93,935.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001931277 Primary reporting owner

Jain Abhishek

Relationship
Chief Financial Officer
Address
C/O CAREDX, INC., 8000 MARINA BLVD., 4TH FLOOR, BRISBANE
Signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact
Signature date
05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Tax liability

Transaction value
$93,935
Shares
-7,687
Change %
-2.3%
Price
$12.22
Shares after
319,725
Date
01 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .